CytomX Therapeutics, Inc. (CTMX) Earnings Signals & AI Vibe Check

Latest Filing: 10-K  |  Filed Mar 16, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for CytomX Therapeutics, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, CytomX Therapeutics, Inc.'s filing signal turned negative.
earningsVibe SuperAnalyst™ Verdict: TURNED NEGATIVE

Signal Performance — Stock Price Since Filing

30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Negative
CLAUDE
Turned Negative
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does CytomX Therapeutics, Inc. actually do?
Answer:
CytomX Therapeutics is a clinical-stage biopharmaceutical company focused on developing conditionally activated biologics for oncology, leveraging its proprietary PROBODY platform. This technology masks potent therapeutics until they reach the tumor microenvironment, aiming to improve selectivity and reduce toxicity. The company's lead programs include Varsetatug masetecan (Varseta-M), an antibody-drug conjugate targeting EpCAM for colorectal cancer, and CX-801, a masked interferon alpha-2b for various solid tumors. CytomX has established strategic collaborations with major biopharmaceutical companies like Amgen, Bristol Myers Squibb, Astellas Pharma, Moderna, and Regeneron to advance its pipeline.
Question:
What are CytomX Therapeutics, Inc.'s revenue drivers?
Answer:
Revenue is primarily derived from non-refundable license payments, milestone payments, and research and development reimbursements under collaboration and license agreements with partners.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required